Featured News

COMPANY

Innovator-of-Year to AMPEL

Innovator-of-Year to AMPEL

CBIC of Virginia honored the  team with “Innovator-of-the-Year” last night June 1st for the AMPEL Genomic Platform of RNA analytics and Machine Learning for dynamic disease management through flare prediction & personalized decision support for drug options. Charlottesville Business Innovation Council (CBIC) presented AMPEL’s “Innovator-of-the-Year” award at the University of Virginia Research Park.

read more
Virginia Workforce Award to AMPEL BioSolutions

Virginia Workforce Award to AMPEL BioSolutions

Virginia officials recognized AMPEL BioSolutions for their dedication to identifying, training, and retaining STEM-trained workers, especially in the area of precision medicine. The annual award recognizes Virginia employers who provide high-quality internships to students.

read more
Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee

Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee

The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2 million in grants to four life and bioscience projects in the Commonwealth of Virginia, pending execution of the grant agreements.

read more

PLATFORM

PRODUCTS

Revolutionizing Lupus Care with Advanced Predictive Blood Testing

Revolutionizing Lupus Care with Advanced Predictive Blood Testing

AMPEL BioSolutions introduces LuGENE®, a cutting-edge blood test poised to revolutionize the management of systematic lupus erythematosus (SLE). LuGENE® leverages predictive artificial intelligence (AI) to detect genetic biomarkers indicative of inflammation-driven SLE flares, offering clinicians valuable insights for tailored treatment strategies.

read more

PARTNERS

Wellness Approach with Lupus & Krill Oil

Wellness Approach with Lupus & Krill Oil

CLICK FOR ORIGINAL FACEBOOK POST > "Very Interesting. Please Read! Another Lupus Breakthrough!! Wellness Approach to Lupus w/KrillOil Disease activity of #Lupus decreased in a trial of 20sites across the #usa-#canada with Ampel Biosolutions Aker BioMarine ASA-Lupus...

read more

Pin It on Pinterest